Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 202-207 , June 2009

Fullerene nanomaterials potentiate hair growth

Received 13 June 2008 ,Accepted 8 September 2008.

References 

  1. Millar SE. Molecular mechanisms regulating hair follicle development. J Invest Dermatol. 2002;118:216–225
  2. Krause K, Foitzik K. Biology of the hair follicle: the basics. Semin Cutan Med Surg. 2006;25:2–10
  3. Rogers GE. Hair follicle differentiation and regulation. Int J Dev Biol. 2004;48:163–170
  4. Jensen AW, Wilson SR, Schuster DI. Biological applications of fullerenes. Bioorg Med Chem. 1996;4:767–779
  5. Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem. 2003;38:913–923
  6. Quick KL, Ali SS, Arch R, Xiong C, Wozniak D, Dugan LL. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging. 2008;29:117–128
  7. Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A. 1997;94:9434–9439
  8. Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al. Fullerene nanomaterials inhibit the allergic response. J Immunol. 2007;179:665–672
  9. Safer JD, Ray S, Holick MF. A topical parathyroid hormone/parathyroid hormone-related peptide receptor antagonist stimulates hair growth in mice. Endocrinology. 2007;148:1167–1170
  10. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150:186–194
  11. Gobe GC, Strutton GM. An experimental study evaluating the effect of minoxidil on the growth cycle of hair follicles. Acta Derm Venereol. 1989;69:190–194
  12. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc. 1999;4:282–284
  13. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198:89–95
  14. Trueb RM. Aging of hair. J Cosmet Dermatol. 2005;4:60–72
  15. Sowden HM, Naseem KM, Tobin DJ. Differential expression of nitric oxide synthases in human scalp epidermal and hair follicle pigmentary units: implications for regulation of melanogenesis. Br J Dermatol. 2005;153:301–309
  16. Akar A, Arca E, Erbil H, Akay C, Sayal A, Gur AR. Antioxidant enzymes and lipid peroxidation in the scalp of patients with alopecia areata. J Dermatol Sci. 2002;29:85–90
  17. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis. 1996;3:129–135
  18. Dugan LL, Lovett EG, Quick KL, Lotharius J, Lin TT, O'Malley KL. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord. 2001;7:243–246
  19. Porter RM. Mouse models for human hair loss disorders. J Anat. 2003;202:125–131
  20. Libecco JF, Bergfeld WF. Finasteride in the treatment of alopecia. Expert Opin Pharmacother. 2004;5:933–940
  21. Arca E, Acikgoz G, Tastan HB, Kose O, Kurumlu Z. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology. 2004;209:117–125
  22. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39(4 Pt 1):578–589

 Conflict of Interest: All authors are employees of Luna Innovations.

PII: S1549-9634(08)00151-2

doi: 10.1016/j.nano.2008.09.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 202-207 , June 2009

Article Tools

* Image Usage & Resolution